Augmentation of diethylnitrosamine–induced early stages of rat hepatocarcinogenesis by 1,2-dimethylhydrazine

References

• Arya, A., Arya, S., and Arya, M., 2011. Chemical carcinogen and cancer risk: an overview. Journal of Chemical and Pharmaceutical Research, 3, 621–631.
   Google Scholar
• Asaoka, Y., et al., 2010. Detection of initiation activity of 1,2-dimethylhydrazine in in vivo medium-term liver initiation assay system using 4-week-old rats without hepatocellular proliferative stimuli during the test chemical treatment period. Journal of Veterinary Medical Science, 72, 43–53.
   PubMed Web of Science ®Google Scholar
• Baba, A.I. and Catoi, C., 2007. Chapter 2, Carcinogenesis. Comparative oncology. Bucharest: The Publishing House of the Romanian Academy.
   Google Scholar
• Bakiri, L. and Wagner, E.F., 2013. Mouse models for liver cancer. Molecular Oncology, 7, 206–223.
   PubMed Web of Science ®Google Scholar
• Caviglia, J.M. and Schwabe, R.F., 2015. Mouse models of liver cancer. Methods in Molecular Biology, 1267, 165–183.
   PubMedGoogle Scholar
• De Robertis, M., et al., 2011. The AOM/DSS murine model for the study of colon carcinogenesis: from pathways to diagnosis and therapy studies. Journal of Carcinogenesis, 10, 9.
   PubMedGoogle Scholar
• Donato, M.T., et al., 1998. Human hepatocyte growth factor down-regulates the expression of cytochrome P450 isozymes in human hepatocytes in primary culture. Journal of Pharmacology and Experimental Therapeutics, 284, 760–767.
   PubMed Web of Science ®Google Scholar
• Femia, A.P. and Caderni, G., 2008. Rodent models of colon carcinogenesis for the study of chemopreventive activity of natural products. Planta Medica, 74, 1602–1607.
   PubMed Web of Science ®Google Scholar
• Ghia, M., Mattioli, F., and Mereto, E., 1996. A possible medium-term assay for detecting the effects of liver and colon carcinogens in rats. Cancer Letters, 105, 71–75.
   PubMed Web of Science ®Google Scholar
• Gonzalez, F.J., 2007. CYP2E1. Drug Metabolism & Disposition, 35, 1–8.
   PubMed Web of Science ®Google Scholar
• Guengerich, F.P., et al., 2009. Measurement of cytochrome P450 and NADPH-cytochrome P450 reductase. Nature Protocols, 4, 1245–1251.
   PubMed Web of Science ®Google Scholar
• Ito, N., et al., 1996. Medium-term liver and multi-organ carcinogenesis bioassays for carcinogens and chemopreventive agents. Experimental and Toxicologic Pathology, 48, 113–119.
   PubMed Web of Science ®Google Scholar
• Kang, J.S., et al., 2007. Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo. Cancer Research, 67, 11141–11146.
   PubMed Web of Science ®Google Scholar
• Kondo, N., et al., 2010. DNA damage induced by alkylating agents and repair pathways. Journal of Nucleic Acids, 2010, 543531.
   PubMedGoogle Scholar
• Kuraishy, A., Karin, M., and Grivennikov, S.I., 2011. Tumor promotion via injury- and death-induced inflammation. Immunity, 35, 467–477.
   PubMed Web of Science ®Google Scholar
• Liu, F., et al., 2014. Glutathione S-transferase A1 (GSTA1) release, an early indicator of acute hepatic injury in mice. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association, 71, 225–230.
   PubMed Web of Science ®Google Scholar
• Lowry, O.H., et al., 1951. Protein measurement with the Folin phenol reagent. The Journal of Biological Chemistry, 193, 265–275.
   PubMed Web of Science ®Google Scholar
• Perse, M. and Cerar, A., 2011. Morphological and molecular alterations in 1,2-dimethylhydrazine and azoxymethane induced colon carcinogenesis in rats. Journal of Biomedicine and Biotechnology, 2011, 473964.
   PubMedGoogle Scholar
• Porter, T.D., 2012. New insights into the role of cytochrome P450 reductase (POR) in microsomal redox biology. Acta Pharmaceutica Sinica B, 2, 102–106.
   Web of Science ®Google Scholar
• Punvittayagul, C., et al., 2011. Effect of pinocembrin isolated from Boesenbergia pandurata on xenobiotic-metabolizing enzymes in rat liver. Drug Metabolism Letters, 5, 1–5.
   PubMedGoogle Scholar
• Rosenberg, D.W., Giardina, C., and Tanaka, T., 2009. Mouse models for the study of colon carcinogenesis. Carcinogenesis, 30, 183–196.
   PubMed Web of Science ®Google Scholar
• Rundle, A., 2006. Carcinogen-DNA adducts as a biomarker for cancer risk. Mutation Research, 600, 23–36.
   PubMed Web of Science ®Google Scholar
• Shivapurkar, N., et al., 1996. A rapid dual organ rat carcinogenesis bioassay for evaluating the chemoprevention of breast and colon cancer. Cancer Letters, 100, 169–179.
   PubMed Web of Science ®Google Scholar
• Summart, R. and Chewonarin, T., 2014. Purple rice extract supplemented diet reduces DMH induced aberrant crypt foci in the rat colon by inhibition of bacterial β-glucuronidase. Asian Pacific Journal of Cancer Prevention, 15, 749–755.
   PubMedGoogle Scholar
• Swenberg, J.A., et al., 2011. Endogenous versus exogenous DNA adducts: their role in carcinogenesis, epidemiology, and risk assessment. Toxicological Sciences, 120, (S1), S130–S145.
   Web of Science ®Google Scholar
• Thumvijit, T., et al., 2014. Cancer chemopreventive effect of Spirogyra neglecta (Hassall) Kützing on diethylnitrosamine-induced hepatocarcinogenesis in rats. Asian Pacific Journal of Cancer Prevention, 15, 1611–1616.
   PubMedGoogle Scholar
• Torre, L.A., et al., 2015. Global cancer statistics, 2012. CA: A Cancer Journal for Clinicians, 65, 87–108.
   PubMed Web of Science ®Google Scholar
• Tsuda, H., et al., 2010. A medium-term, rapid rat bioassay model for the detection of carcinogenic potential of chemicals. Toxicologic Pathology, 38, 182–187.
   PubMed Web of Science ®Google Scholar
• Zanger, U.M. and Schwab, M., 2013. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacology & Therapeutics, 138, 103–141.
   PubMed Web of Science ®Google Scholar